Condition
HPV (Human Papillomavirus)-Associated Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 HPV (Human Papillomavirus)-Associated Carcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (3), South Korea (1)). By phase: Phase 2 (3), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest HPV (Human Papillomavirus)-Associated Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Selective dose reduction of neck radiation in HPV-associated oropharyngeal cancer | Phase 2 | Baltimore, Maryland and 3 other locations | Recruiting | Feb 18, 2026 |
| Neoadjuvant chemoimmunotherapy with PD-1 blockade to reduce surgery for advanced head and neck cancer | Phase 2 | Baltimore, Maryland | Recruiting | Oct 6, 2025 |
| BVAC-E6E7 immunotherapy for HPV-positive head and neck cancer | Phase 1/2 | Seoul and 1 other locations | Recruiting | Jan 29, 2025 |
| Combination of HPV Vaccine, Imiquimod, and Metformin for Cancer Treatment | Phase 2 | Houston, Texas and 1 other locations | Recruiting | Nov 13, 2024 |
All recruiting trials (4)
-
Selective dose reduction of neck radiation in HPV-associated oropharyngeal cancer
This trial tests whether lowering radiation doses to certain neck lymph nodes or gross disease areas is safe and can reduce side effects for adults with HPV-related oropharyngeal cancer.
-
Neoadjuvant chemoimmunotherapy with PD-1 blockade to reduce surgery for advanced head and neck cancer
This approach will try a short course of chemotherapy plus the PD-1 drug toripalimab before standard treatment for people with advanced head and neck cancers to shrink tumors and allow less extensive surgery or radiation.
-
BVAC-E6E7 immunotherapy for HPV-positive head and neck cancer
A one-time immunotherapy shot called BVAC-E6E7 is being tested to see if it helps adults with HPV-positive head and neck cancer that has come back or spread.
-
Combination of HPV Vaccine, Imiquimod, and Metformin for Cancer Treatment
This study is testing if a combination of an HPV vaccine, a skin treatment called imiquimod, and a diabetes drug called metformin can help people with advanced cervical, vaginal, or vulvar cancer live longer without their cancer getting worse.
Related topics
Quick answers
How many HPV (Human Papillomavirus)-Associated Carcinoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (3 trials), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.